Literature DB >> 16388629

Regioselective copper-catalyzed amination of chlorobenzoic acids: synthesis and solid-state structures of N-aryl anthranilic acid derivatives.

Xuefeng Mei1, Adam T August, Christian Wolf.   

Abstract

[reaction, structure: see text] A chemo- and regioselective copper-catalyzed cross-coupling reaction for effective amination of 2-chlorobenzoic acids with aniline derivatives has been developed. The method eliminates the need for acid protection and produces a wide range of N-aryl anthranilic acid derivatives in up to 99% yield. The amination was found to proceed with both electron-rich and electron-deficient aryl chlorides and anilines and also utilizes sterically hindered anilines such as 2,6-dimethylaniline and 2-tert-butylaniline. The conformational isomerism of appropriately substituted N-aryl anthranilic acids has been investigated in the solid state. Crystallographic analysis of seven anthranilic acid derivatives showed formation of two distinct supramolecular architectures exhibiting trans-anti and unprecedented trans-syn dimeric structures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16388629      PMCID: PMC2533712          DOI: 10.1021/jo0518809

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  35 in total

1.  From molecules to crystal engineering: supramolecular isomerism and polymorphism in network solids.

Authors:  B Moulton; M J Zaworotko
Journal:  Chem Rev       Date:  2001-06       Impact factor: 60.622

2.  A general and efficient copper catalyst for the amidation of aryl halides and the N-arylation of nitrogen heterocycles.

Authors:  A Klapars; J C Antilla; X Huang; S L Buchwald
Journal:  J Am Chem Soc       Date:  2001-08-08       Impact factor: 15.419

Review 3.  Intercalators as anticancer drugs.

Authors:  M F Braña; M Cacho; A Gradillas; B de Pascual-Teresa; A Ramos
Journal:  Curr Pharm Des       Date:  2001-11       Impact factor: 3.116

4.  Rational design of potent human transthyretin amyloid disease inhibitors.

Authors:  T Klabunde; H M Petrassi; V B Oza; P Raman; J W Kelly; J C Sacchettini
Journal:  Nat Struct Biol       Date:  2000-04

5.  Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors.

Authors:  Vibha B Oza; Craig Smith; Prakash Raman; Edward K Koepf; Hilal A Lashuel; H Mike Petrassi; Kyle P Chiang; Evan T Powers; James Sachettinni; Jeffery W Kelly
Journal:  J Med Chem       Date:  2002-01-17       Impact factor: 7.446

Review 6.  Interest of acridine derivatives in the anticancer chemotherapy.

Authors:  M Demeunynck; F Charmantray; A Martelli
Journal:  Curr Pharm Des       Date:  2001-11       Impact factor: 3.116

7.  3-Aryl-2-oxazolidinones through the palladium-catalyzed N-arylation of 2-oxazolidinones.

Authors:  S Cacchi; G Fabrizi; A Goggiamani; G Zappia
Journal:  Org Lett       Date:  2001-08-09       Impact factor: 6.005

8.  Antimalarial, antitrypanosomal, and antileishmanial activities and cytotoxicity of bis(9-amino-6-chloro-2-methoxyacridines): influence of the linker.

Authors:  S Girault; P Grellier; A Berecibar; L Maes; E Mouray; P Lemière; M A Debreu; E Davioud-Charvet; C Sergheraert
Journal:  J Med Chem       Date:  2000-07-13       Impact factor: 7.446

9.  Room-Temperature Palladium-Catalyzed Amination of Aryl Bromides and Chlorides and Extended Scope of Aromatic C-N Bond Formation with a Commercial Ligand.

Authors:  John F. Hartwig; Motoi Kawatsura; Sheila I. Hauck; Kevin H. Shaughnessy; Luis M. Alcazar-Roman
Journal:  J Org Chem       Date:  1999-07-23       Impact factor: 4.354

10.  Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid.

Authors:  P W Baures; V B Oza; S A Peterson; J W Kelly
Journal:  Bioorg Med Chem       Date:  1999-07       Impact factor: 3.641

View more
  6 in total

1.  Pharmacological comparison of novel synthetic fenamate analogues with econazole and 2-APB on the inhibition of TRPM2 channels.

Authors:  Gui-Lan Chen; Bo Zeng; Sarah Eastmond; Sandra E Elsenussi; Andrew N Boa; Shang-Zhong Xu
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

2.  Synthesis and antimalarial activity of new 4-amino-7-chloroquinolyl amides, sulfonamides, ureas and thioureas.

Authors:  Kekeli Ekoue-Kovi; Kimberly Yearick; Daniel P Iwaniuk; Jayakumar K Natarajan; John Alumasa; Angel C de Dios; Paul D Roepe; Christian Wolf
Journal:  Bioorg Med Chem       Date:  2008-11-12       Impact factor: 3.641

3.  Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials.

Authors:  Rozalia A Dodean; Papireddy Kancharla; Yuexin Li; Victor Melendez; Lisa Read; Charles E Bane; Brian Vesely; Mara Kreishman-Deitrick; Chad Black; Qigui Li; Richard J Sciotti; Raul Olmeda; Thu-Lan Luong; Heather Gaona; Brittney Potter; Jason Sousa; Sean Marcsisin; Diana Caridha; Lisa Xie; Chau Vuong; Qiang Zeng; Jing Zhang; Ping Zhang; Hsiuling Lin; Kirk Butler; Norma Roncal; Lacy Gaynor-Ohnstad; Susan E Leed; Christina Nolan; Stephanie J Huezo; Stephanie A Rasmussen; Melissa T Stephens; John C Tan; Roland A Cooper; Martin J Smilkstein; Sovitj Pou; Rolf W Winter; Michael K Riscoe; Jane X Kelly
Journal:  J Med Chem       Date:  2019-03-21       Impact factor: 7.446

4.  N-aryl-6-methoxy-1,2,3,4-tetrahydroquinolines: a novel class of antitumor agents targeting the colchicine site on tubulin.

Authors:  Xiao-Feng Wang; Sheng-Biao Wang; Emika Ohkoshi; Li-Ting Wang; Ernest Hamel; Keduo Qian; Susan L Morris-Natschke; Kuo-Hsiung Lee; Lan Xie
Journal:  Eur J Med Chem       Date:  2013-06-29       Impact factor: 6.514

5.  Regioselective Copper-catalyzed C-N and C-S Bond Formation using Amines, Thiols and Halobenzoic Acids.

Authors:  Shuanglong Liu; John Paul C Pestano; Christian Wolf
Journal:  Synthesis (Stuttg)       Date:  2007-11-16       Impact factor: 3.157

6.  Solution growth and thermal treatment of crystals lead to two new forms of 2-((2,6-dimethylphenyl)amino)benzoic acid.

Authors:  Rong Hu; Yunping Zhoujin; Meng Liu; Mingtao Zhang; Sean Parkin; Panpan Zhou; Jianzhi Wang; Faquan Yu; Sihui Long
Journal:  RSC Adv       Date:  2018-04-24       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.